Kingworld Imada Red Flower Oil Makes Official Topical Oil of Shenzhen Bao’an Marathon Headquartered in Shenzhen, Kingworld Medicines Group Limited…
Browsing: BioTech
Group reports lower revenue for 2Q on switch to immunotherapy and cell therapies from vaccines Malaysian Genomics Resource Centre Berhad,…
Strengthening Gastrointestinal Endotherapy Offerings Through Bringing Together Talent and Technology Olympus Corporation (Olympus), a global medtech company committed to making…
Essex Bio-Technology Ltd (Essex or the Group, HKG: 1061) today announced that two of its wholly-owned subsidiaries, Essex Bio-Investment Limited…
Group in strategic collaboration with Divine Genes to offer genetic tests related to reproductive health in Malaysia and overseas Malaysian…
Shenzhen Macrolux Medical Technology Co., Ltd. (hereinafter referred to as Macrolux) recently announced the completion of its Series A round…
Legend Capital invested in 29 healthcare companies that officially disclosed financing rounds in 2022, according to the VBDATA Database. Since…
Novotech, the leading Asia Pacific centred biotech CRO with extensive experience in vaccine trials, is convening an expert panel webinar…
Further Enhance the Group’s Strategic Partnership with Insurance Sector and Enrich the Group’s Enclosed Healthcare Ecosystem EC Healthcare (the Company,…
Novotech, the leading Asia Pacific centred biotech CRO, has published a new global report on Phase 1 trial activity including…
Essex Bio-Technology Ltd (Essex or the Group, HKG: 1061) today announced that the first patient in the United States (US)…
Novotech, the leading Asia Pacific focused biotech specialist CRO and recipient of the Asia Pacific Cell & Gene Therapy Clinical…
Novotech announced today the acquisition of EastHORN, a European CRO with clinical, medical and regulatory expertise in multiple strategically important…
Expands Drug Development and FDA Regulatory Expertise Novotech, the leading Asia Pacific-centered biotech CRO today announced the acquisition of CBR…
HighTide Therapeutics Inc. (HighTide), a globally integrated clinical-stage biopharmaceutical company developing novel multifunctional therapies for metabolic and digestive diseases, today…
More than 40 biotech clients are now taking advantage of Avance Clinical’s GlobalReady program which delivers streamlined clinical development from…
Prenetics has completed the majority stake acquisition of ACT Genomics to spearhead its entry into to the US$80+ billion global…
China Biotech Services Holdings Limited (the Group; HKG: 8037) has announced that its subsidiary, Asia Molecular Diagnostics Laboratory (AMDL), has…
Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, is pleased to announce a strategic…
Global biopharmaceutical company focusing on metabolic and digestive diseases Proceeds to fund clinical and business development HighTide Therapeutics Inc. (HighTide),…